Resource

Considerations and Opportunities in Capturing Oncology Patients’ PRO Data

There has been a historic lack of guidance in capturing patient data for oncology patients. Join Bill Byrom, VP and eCOA Scientist at Signant Health in conversation with Mark Wade, Global Practice Leader at TransPerfect, as they discuss: - The need for specificity of instruments to lead to greater use of PRO data in labeling claims - The impact of the draft FDA guidance to instrument selection and COA measurement strategy - The potential of item banks and augmentation of...

Resource

Building a Successful Partnership: Meeting Sponsor Expectations

To improve clinical trial electronic system development, strong partnerships must be built and maintained between key stakeholders to establish centralized consensus and alignment for high-quality electronic data capture. Join Aaron McCormick, Associate Director, eCOA Implementation at Moderna in conversation with Mark Wade, Global Practice Leader at TransPerfect, as they dive into: - Building and maintaining Sponsor eCOA standards. - Establishing a strong working...

Resource

Considerations for Improving the Pediatric Experience

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: The disparity in data capture for pediatric populations. Considerations for...

Resource

Enabling Diversity & Inclusion in Clinical Trials: A CRO & IRB Perspective

Diversity in clinical research is imperative to ensure the safety and effectiveness of drugs and medical devices for all people—and everyone in the industry is a key stakeholder. Clinical trials today still lack ethnic diversity, and to make trials more inclusive and improve equity in research, we ALL have a part to play. TransPerfect Life Sciences’ webinar series will take a closer look into each stakeholder’s role, current challenges, misconceptions, and activities for...

Resource

Be Where Your Patients Are: Effective Digital Strategies For Patient Recruitment

Did you know that 15–20% of studies do not launch due to unsuccessful patient enrollment? In the past, recruiting the RIGHT patient population has been complex, expensive, and challenging, especially when it comes to rare diseases or niche requirements. Join TPT Digital’s Director Brian Hansen to discuss how: - Digital marketing is an easy, inexpensive, and effective tool for patient recruitment - TPT Digital helped Amarex, a global CRO, recruit LGBTQ, HIV positive...

Resource

Wearables for eCOA: Practical Considerations for Improving Patient Data Capture

This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization, it is clear that newer technologies such as accelerometers and video have the ability to passively or proactively gather more patient data. These wearable devices offer significant advantages in terms...

Resource

How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices, and common pitfalls to avoid in order to maximise value and mitigate risk in life sciences dealmaking, and also answer audience questions. Topics discussed include: - The importance of...

Resource

A Conversation with Dr. Elin Haf Davies of Aparito

The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & CEO of Aparito, in conversation with Mark Wade, Global Practice Leader at TransPerfect Life Sciences, as they discuss: - The disparity in data capture for pediatric populations. - Considerations...

Resource

Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU Clinical Trial Regulation became compulsory for all new interventional clinical trials of investigational medicinal products. All ongoing trials approved under the previous regulatory framework (EU...

Resource

Part 2: Clinical Trials and COVID-19 Converting to Remote Trial Management – How to Get Started

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive hosted Part 2 of the Clinical Trials and COVID-19 webinar series with industry experts to discuss the best strategy to make the...

Resource

Part 4: Clinical Trials and COVID-19: Remote Investigator Meetings

The novel COVID-19 virus has forced a lot of rapid changes in a very short period. Personally and professionally, we are all learning how to adapt. While restrictions on our day-to-day lives impact where, why, and how we interact, we still can come together as a community to learn, grow, and overcome. TransPerfect's Trial Interactive presents Part 4 of the Clinical Trials and COVID-19 webinar series with industry-expert Penelope K. Manansco to discuss the best...

Resource

Driving Strategic Change: General Counsel in Pharma

TransPerfect Legal Solutions hosted a panel of GCs and legal experts from prominent pharmaceutical companies to discuss their evolving roles and the practical ways legal departments are driving innovation as it relates to people, risk, and data in the pharma industry. PANELISTS: Zafar Qadir – General Counsel, Bicycle Therapeutics Alexandra Pygall – Partner, Head of Life Sciences, Stephenson Harwood Keir LoIacano – Counsel and Vice President of Corporate Development,...